CURRICULUM VITAE
Ahmed Zayed Obeidat MD, PhD
Ahmed Zayed Obeidat MD, PhD
Associate Professor
Department of Neurology
Division of General
Department of Neurology
Division of General
OFFICE ADDRESS: |
Hub for Collaborative Medicine |
8701 Watertown Plank Road |
Milwaukee, WI 53226 |
Fax: 4149550127 |
EDUCATION: |
10/01/2002 - 06/30/2008 MBBS, Jordan University of Science and Technology, Irbid, Jordan |
09/01/2009 - 05/30/2013 Ph.D. (Doctor of Philosophy), Wright State University, Dayton, OH |
05/25/2015 - 05/27/2015 Non-degree - program name: Master of Multiple Sclerosis |
07/01/2019 - 06/03/2020 Certificate of Medical Education-Educational Transformation in Teaching, Kern Institute, Medical College of Wisconsin, Milwaukee, WI |
POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS: |
07/01/2008 - 07/15/2009 Intern physician, Internal Medicine, Surgery, Pediatrics, Ministry of Health Hospitals, Irbid - Jordan |
07/01/2013 - 06/30/2014 Medical Internship, Internal Medicine, University of Cincinnati, Cincinnati, OH |
07/01/2014 - 06/30/2017 Resident Physician, Neurology, University of Cincinnati, Cincinnati, OH |
07/01/2017 - 06/30/2018 Fellow Physician, Neurology, Neuroimmunology and Multiple Sclerosis, University of Cincinnati, Cincinnati, OH |
FACULTY APPOINTMENTS: |
07/01/2018 - Present Assistant Professor, Neurology, Neuroimmunology and Multiple Sclerosis, Medical College of Wisconsin, Milwaukee, WI 53226 |
EDUCATIONAL ADMINISTRATIVE APPOINTMENTS: |
09/01/2018 - Present Founding Director, Neuroimmunology & MS Fellowship Program, Neurology, Medical College of Wisconsin |
HOSPITAL STAFF PRIVILEGES: |
07/16/2018 - Present Staff Physician, Neurology, Froedtert and the Medical College of Wisconsin |
10/01/2020 - Present Staff Physician, Neurology, Children's Hospital of Wisconsin |
SPECIALTY BOARDS AND CERTIFICATION: |
Board Certified | Issue Date | Expiration |
American Board of Psychiatry and Neurology ABPN | 09/11/2017 | 09/10/2027 |
Licensure | Number | Issue Date | Expiration |
Medicine and Surgery | 69028 | 03/22/2018 | 10/31/2021 |
AWARDS AND HONORS: |
08/2002 National (Tawjihi) Certification Exam (National High School Cumulative Exam): Score of 96.4%, among the top 100 scores in the nation, National Jordanian High School Exam |
09/2002 - 06/2008 Faculty of Medicine honor list, Top 5% of class, Jordan University of Science and Technology |
2002 - 2003 President’s honor list, Jordan University of Science and Technology |
01/2008 - 03/2008 Travel Award to the University of Texas
Medical Branch, Galveston, TX in support of two months elective training in
Clinical Neurology, International Brain Research Organization (IBRO) |
06/2008 Ranked 4th among 315 medical school graduates , Jordan University of Science and technology |
01/2010 - Present Travel Award to Mahidol University, Bangkok-Thailand for attending the 14th IBRO‐APRC Associate School of Neuroscience
“Synaptic Plasticity: From Basics to Clinical applications, International Brain Research Organization (IBRO) |
06/01/2010 - Present Phi Kappa Phi Inductee, The Phi Kappa Phi Honor Society |
2010 The most engaging country display “JORDAN,” during the 26th Annual Friendship Affair, Wright State University |
05/18/2011 Graduate Student Excellence Award , Wright State University |
06/01/2011 - Present Nominated member to the American Association for the Advancement of Science / Program for Excellence in Science , AAAS |
08/30/2011 First Place Superior Platform Presentation , Wright State University |
04/2012 Graduate Student Assembly Professional Development Award in support of attending the American Physician Scientist Association 8th Annual Meeting, Wright State University |
05/01/2012 - 06/30/2013 President's Ambassador, Wright State University |
05/2012 Best Poster Award , Ohio Miami Valley Society for Neuroscience |
08/2012 Internal Pilot Grant - Recurrent Inhibition , Wright State University |
2012 American Physician Scientist Association Travel Award, American Physician Scientist Association |
11/2014 Above and Beyond Resident Award, University of Cincinnati |
12/2014 Above and Beyond Resident Award, University of Cincinnati |
05/2015 cholarship to attend the Consortium of Multiple Sclerosis Centers Annual Meeting, The Consortium of MS Centers |
05/2015 Resident Scholar Award , The Foundation of the Consortium of Multiple Sclerosis Centers |
06/2015 Scholarship to attend the Clinical Neuroscience Expo, University of Kentucky |
08/2015 Scholarship to attend Gordon Research Conference: Inhibition in the CNS |
12/2015 Above and Beyond Resident Award, University of Cincinnati |
2015 PCORI travel award to attend PCORI annual meeting, The Patient-Centered Outcomes Research Institute |
02/2016 The International Junior Stroke Investigator Award , International Stroke Organization |
10/2016 "Best in Class" Multiple Sclerosis Challenging Cases, PRIME's GME Today Advance Practice in Multiple Sclerosis |
2016 - 2018 Educational Grant Travel Award - 3 consecutive years, ACTRIMS |
2016 PCORI travel award to attend the “Getting to Know PCORI, The Patient-Centered Outcomes Research Institute |
01/2017 Above and Beyond Resident Award, University of Cincinnati |
04/2017 Resident Scholarship to the Annual Meeting, The American Academy of Neurology |
07/01/2017 - 06/30/2018 NMSS Clinical Care Fellowship, National Multiple Sclerosis Society |
09/01/2017 - Present Alpha Omega Alpha Inductee , Alpha Omega Alpha Honor Medical Society |
2017 - 2018 Clinical Care Fellowship, National MS Society |
04/2018 Fellow Scholarship to the Annual Meeting, The American Academy of Neurology |
10/10/2018 Certificate of Appreciation in recognition of superior performance , Neuroscience Clinic Management |
2018 Fellow Award and Annual Meeting Scholarship, American Academy of Neurology |
2019 Top Patient Experience Award, Froedtert and the Medical College of Wisconsin |
2019 - 2020 Outstanding Medical Student Teaching Award, Medical College of Wisconsin |
2020 Faculty Global Health Travel Scholarship, Medical College of Wisconsin |
2020 Imagine More Award, Neuroscience Research Center |
06/13/2021 Most Impactful Team Award, Tech Serum - Microsoft Healthcare's Hackathon |
MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES: |
2005 - 2009 Jordanian Cystic Fibrosis Society |
2006 - 2009 Jordanian Multiple Sclerosis Society |
2007 - Present Society for Arab Neuroscientists |
2007 - 2009 Jordanian Family and Child Protection Society |
2007 - Present International Brain Research Organization (IBRO) |
2010 - Present American Physician Scientist Association |
2010 - Present The Phi Kappa Phi Honor Society |
2010 - Present Society for Neuroscience |
2011 - Present The American Association for the Advancement of Science/ Program for Excellence in Science |
2013 - Present American Academy of Neurology |
2015 - Present Foundation of the Consortium of Multiple Sclerosis Centers |
2015 - Present The Consortium of Multiple Sclerosis Centers |
2015 - 2016 The American Heart Association |
09/2017 - Present Alpha Omega Alpha Honor Medical Society |
2017 - Present Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) |
EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS: |
Editorship |
2021 - Present GENERATIONS - a publication by the Consortium of MS Centers and the Foundation of the CMSC |
Editorial Board |
01/01/2019 - 01/01/2022 International Journal of MS Care |
04/01/2021 - Present Multiple Sclerosis and Neuroimmunology (specialty section of Frontiers in Immunology and Frontiers in Neurology) |
Journal Review |
Journal of Pediatric Neurology |
Neurology |
Multiple Sclerosis Journal |
Journal of Child Neurology |
Avicenna Journal of Medicine |
Journal of Translational Medicine |
Journal of Neurological Sciences |
Journal of Pediatric Neurology |
Multiple Sclerosis and Related Disorders |
Multiple Sclerosis Journal – Experimental, Translational and Clinical |
Reviews in the Neurosciences |
The Permanente Journal |
LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS: |
2005 - 2009 Member, Executive Committee, Jordanian Cystic Fibrosis Society |
2012 Chair, Research Symposium Organizing Committee, Graduate Student Assembly, Wright State University |
2015 - 2016 Member, Resident Advisory Council, University of Cincinnati |
2018 - Present Member, Neurology Resident Selection Committee, Medical College of Wisconsin |
2019 - Present Scientific Review Member, Institutional Review Board (IRB) - Committee #4, Medical College of Wisconsin |
2021 - Present Member, MSTP Director search committee, Medical College of Wisconsin |
NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS: |
2014 - Present Communication Officer, Executive Committee, Society for Arab Neuroscientists |
2016 - 2019 Co-Chair, MS Professionals-in- Training Special Interest Group (MS-PiT), The Consortium of MS Centers |
2016 - Present Member, Board of Governors, The Consortium of MS Centers |
2016 Co-Chair, President Search Committee, Society for Arab Neuroscientists |
2017 - 2018 Member, Ohio Delegation, American Academy of Neurology - Neurology on the Hill |
2018 - 2024 Director of Research, Board of Directors, Global Music and Wellness |
2019 - 2022 Member, Advisory Committee, Americas Committee for the Treatment and Research in Multiple Sclerosis (ACTRIMS) |
2019 - Present Member, Education Subcommittee, American Academy of Neurology MS Section |
2019 - Present Chair, MS Professionals-in- Training Special Interest Group (MS-PiT), Consortium of MS Centers |
2019 - Present Member, Mentorship Forum Organizing Committee, Foundation of the Consortium of MS Centers |
2020 - Present Member, National Didactic Planning Committee, ACTRIMS |
2020 - 2021 Scientific Review Member, Scientific Abstract review, Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) |
2020 - 2021 Scientific Panelist, Peer review panel of the 2020 Multiple Sclerosis Research Program (MSRP), Department of Defense Congressionally Directed Medical Research Programs (CDMRP) |
2020 - 2021 Scientific Reviewer, Research Grant Review Committee, The Foundation of the Consortium of MS Centers |
2020 - Present Member, Neuroimmunology and MS Fellowship National Curriculum Development and Subspecialty Certification Committee, Multiple Organizations |
05/2021 - Present Expert Faculty Member, Best practices in the Use of Disease-Modifying Therapies in MS, The Consortium of MS Centers |
2021 Scientific Review Member, Scientific Abstract review, The Consortium of MS Centers |
2021 Scientific Review Member, Scientific Abstract review, American Academy of Neurology |
INTERNATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS: |
01/2007 - 01/2008 Secretary, United Arab Emirates neuroscience school, International Brain Research Organization
(IBRO) |
2008 - 2009 Member, Abstract Review, International Online Medical Student Conference |
RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
INVITED LECTURES/WORKSHOPS/PRESENTATIONS: |
International |
Ahmed Obeidat, Highlights of My Experience While Communicating with Elderly in Dementia Research, First Arab Neuroscience School, Faculty of Medicine, United Arab Emirates University, Al Ain, UAE, 11/2007 |
Ahmed Obeidat, Multiple Sclerosis in Jordan: Epidemiology and Achievements, Department of Neurology weekly seminar, University of Texas Medical Branch at Galveston, TX, 02/2008 |
Ahmed Obeidat, atest scientific developments in the diagnosis and treatment of multiple sclerosis (MS) and neuro-immunological diseases, Hospital-Wide Grand Rounds, Jordan University of Science and Technology and King Abdullah University Hospital, 07/01/2019 |
Ahmed Obeidat, Professor Clinical Rounds, King Abdullah University Hospital, Irbid, Jordan, 07/14/2019 - 07/15/2019 |
National |
Ahmed Obeidat, Navigating Your Career: Training in Neurology While on a Visa: Challenges and Possible Solutions for Foreign Medical Graduates, American Academy of Neurology Annual Meeting in 2017 and in 2018 (invited again due to the lecture impact), Boston, MA and Los Angeles, CA, 2017 - 2018 |
Ahmed Obeidat, Navigating Your Career: Navigating Fellowship in Neurology, American Academy of Neurology Annual Meeting 2017 and 2018 - Invited again in 2018 due to the lecture impact, Boston, MA and Los Angeles, CA, 2017 - 2018 |
Ahmed Obeidat, Medical Humanities, reflective writing, and visual arts in multiple sclerosis, CMSC Annual Meeting, Seattle Washington, 2019 |
Ahmed Obeidat, Selected Hot Topics in MS, Grand Rounds, Novartis headquarters, East Hanover, NJ, 03/12/2020 |
Ahmed Obeidat, B cells as a therapeutic target in Multiple Sclerosis: Past, Present and Future, Grand Rounds, George Washington Neurology Department, 11/03/2020 |
Ahmed Obeidat, A group leader for a Gather-Ed CME experience entitled: “Following the Trail of Evidence to Individualize and Optimize Multiple Sclerosis Care”, Online, https://spire.gathered.com/group/208/dashboard, 02/02/2021 - 07/15/2021 |
Regional |
Ahmed Obeidat, Multiple Sclerosis: Is it the Price Paid for Untreated Emotional Seizure(s) in Susceptible Individuals?, University of Toledo Midwest Graduate Research Symposium, Toledo, OH, 03/2011 |
Ahmed Obeidat, Recurrent Inhibition and Peripheral Nerve Injury, University of Toledo Midwest Graduate Research Symposium, Toledo, OH, 03/2012 |
Ahmed Obeidat, Technology in MS care – An opportunity to make an impact, Biomedical Engineering Seminar series., Marquette University. Milwaukee, WI, 12/06/2019 - Present |
Local |
Ahmed Obeidat, Neural tube defects in the north of Jordan: Is there a seasonal variation?, The
Second Conference for Faculty of Medicine at the University of Jordan and 5th Conference for Jordanian Medical Faculties, Amman, Jordan, 05/2009 |
Ahmed Obeidat, Using in Vivo Physiology to Probe the Beauty of a Spinal Circuit, Biomedical Sciences Ph.D. Research Retreat, Wright State University, 08/2011 |
Ahmed Obeidat, The Diverse Capacities of CNS Inhibition, The Neuroscience Seminar Series, University of Cincinnati, 03/2015 |
Ahmed Obeidat, Advances in the Understanding and Treatment of Multiple Sclerosis, Annual Advances in Neurology, Medical College of Wisconsin, 06/14/2019 |
Ahmed Obeidat, Hearing hoofbeats; Think Zorse!, Neurology Grand Rounds, Medical College of Wisconsin, 04/17/2020 |
Ahmed Obeidat, B Cells As a Therapeutic Target in Multiple Sclerosis: Past, Present and Future, Neurology Grand Rounds, Medical College of Wisconsin, 10/14/2020 |
Ahmed Obeidat, Autoimmune CNS disease and neuro manifestations of rheum disease, Rheumatology Conference, Medical College of Wisconsin, 02/24/2021 |
Ahmed Obeidat, Sam Hooshmand, Multiple Sclerosis and its Mimickers: A Case Based Approach, Headache Medicine & General Neurology Virtual CME Symposium, Medical College of Wisconsin, 03/13/2021 |
Ahmed Obeidat, Fading memories, vanishing reminiscence and refractory seizures: To name just a few in the world of Autoimmune Encephalitis, Neuropsychology Seminar, Medical College of Wisconsin, 05/11/2021 |
MCW TEACHING ACTIVITIES: |
Medical Student Education |
03/2019 - Present Myelination disorders - M2 – Basic Science Courses - Yearly teaching |
03/02/2021 Art of Medicine through the Humanities class - Islam and the Medical Ethics: Past and PresentCaring for the Muslim patient |
Resident and Fellow Education |
08/31/2018 Academic Half Day: management of Neuromyelitis Optica in the hospital setting |
11/30/2018 Academic Half Day: Pathophysiology, Diagnosis and Variants of MS |
11/30/2018 Academic Half Day: MS Treatment |
02/22/2019 Joint Academic Half Day with ophthalmology |
11/13/2020 Academic Half Day: MS and related disorders |
12/04/2020 Academic Half day: MS and related disorders |
12/11/2020 Academic Half Day: MS and related disorders |
EXTRAMURAL TEACHING: |
Resident and Fellow Education |
03/06/2019 Community Memorial Hospital Family Medicine Residency, Multiple sclerosis for family medicine |
11/11/2020 Community Memorial Hospital Family Medicine Residency, Neuroimmunology, MS and GBS in primary care |
Community/Lay Public |
11/01/2018 Froedtert/MCW, Multiple Sclerosis and Stress |
03/27/2019 Froedtert/MCW, Technology Integration in Multiple Sclerosis Care |
11/12/2020 Froedtert/MCW, Multiple Sclerosis: What's New? |
MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED: |
Medical Students |
01/01/2020 - Present Mokshal Porwal, Research and Academic mentor, Medical College of Wisconsin, Project: Safety of Disease Modifying therapies in Multiple Sclerosis. Two manuscripts under peer review. Two accepted abstracts, and two manuscripts in final preparation. |
03/01/2020 - Present Calin Dumitrescu, Clinical research and academic mentor, Medical College of Wisconsin, Project: Changes in Immunoglobulins and Lymphocytes in the Peripheral Blood of Patients Receiving B-cell-
depleting Therapies for Multiple Sclerosis and Related Disorders. (one poster presentation; one poster to be presented in October 2021; Medical student research grant from the Foundation of the Consortium of MS Centers). |
06/01/2020 - Present Britta Bureau, Research and Academic mentor, Medical College of Wisconsin, One published manuscript, one conference abstract, and applying for neurology residency. |
04/01/2021 - Present Murali Palathinkara, Research and academic mentorship, Medical College of Wisconsin, Project: Early versus Late Onset Multiple Sclerosis. Awarded the Foundation of the Consortium of MS Centers Research Grant |
04/01/2021 - Present Delaney Cairns, Research and academic mentorship, Medical College of Wisconsin, roject: Ethnic and Racial Variation in clinical features and access to clinical care in people living with Multiple Sclerosis. Awarded the Foundation of the Consortium of MS Centers research grant, and awarded the Wisconsin Medical Society Foundation Summer Fellowship. |
04/01/2021 - Present Camila Ishueva, Research and academic mentorship, Medical College of Wisconsin, Project: Analysis of tremor in multiple sclerosis. Awarded the Foundation of the Consortium of MS Centers research grant. One manuscript in final stages of preparation |
Casey Vickstrom, Academic Advisor, Medical College of Wisconsin |
Clinical/Research Fellows |
07/01/2019 - 06/30/2020 Nicola Carlisle, Program director, research and academic mentor, Medical College of Wisconsin, Completed fellowship in MS and Neuroimmunology. Joined an established neurology group a an MS specialist. published several manuscripts and abstracts. |
07/01/2020 - 06/30/2021 Sam Hooshmand, Program director, research and academic mentor, Medical College of Wisconsin, Completed fellowship in MS and Neuroimmunology, started faculty appointment at MCW. published several manuscripts and abstracts and obtained several research and academic awards |
Residents |
01/01/2019 - Present Allison Block, DO, Research and academic advisor, Medical College of Wisconsin, Project: Anti MOG associated disease. 2 published manuscript, 1 manuscript under peer review, 1 manuscript in final preparation, 3 published abstracts, and one top scoring abstract for ACTRIMS 2021. Also successfully obtained a fellowship position at the University of Chicago |
EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED: |
Medical Students |
07/01/2017 - Present Samuel Marcucci, Research and Academic Mentor, University of Cincinnati, Research grant, one published manuscript, two published abstracts, successful matching into neurology residency |
10/01/2018 - Present Mohammad Adawi, MD, Research and Academic, University of Nebraska Medical Center, Successfully matched in neurology residency at the University of Nebraska. Also, one published abstract and one manuscript in preparation. Project: Anti Ma2 Limbic Encephalitis. |
PROGRAMMATIC DEVELOPMENTS: |
Educational Programs |
Fellow |
07/01/2019 - Present Founded the first fellowship program in Neuroimmunology and Multiple Sclerosis in the state of Wisconsin. |
MEDIA APPEARANCE: |
Article on Wright State University website about my research.
http://webapp2.wright.edu/web1/dialogue/2012/10/spinal-cord-circuit-that-controls-body- movement-focus-of-wright-state-neuroscience-research/
|
Podcast on Music and Wellness WMKV local music radio channel
https://ice7.securenetsystems.net/media/WMKVFM/ondemand/Healthscope%20for%20April%2016th%202018.m4a |
Where Art Meets Science: CMSC Speakers Show How Artistic Expression Can Be Part of MS Management. http://delmedgroup.com/Daily_2019/May30/artistic-expression.html
|
https://www.tmj4.com/news/local-news/multiple-sclerosis-now-impacting-approx-1-million-americans
|
NEUROLOGY LIVE: THE EVERY CHANGING FACE OF MULTIPLE SCLEROSIS: |
This is a series of Webinars that I create, design, prepare and present. In each episode, I invite two experts in the field to discuss a topic related to MS. the events are free to attend and are highly attended by international audience.
https://www.neurologylive.com/authors/ahmed-obeidat-md-phd |
BIBLIOGRAPHY |
Refereed Journal Publications/Original Papers |
1. Obeidat AZ, Amarin Z. Neural tube defects in the north of Jordan: is there a seasonal variation? J Child Neurol. 2010 Jul;25(7):864-6. |
2. Amarin ZO, Obeidat AZ. Effect of folic acid fortification on the incidence of neural tube defects. Paediatr Perinat Epidemiol. 2010 Jul 01;24(4):349-51. |
3. Obeidat AZ, Nardelli P, Powers RK, Cope TC. Modulation of motoneuron firing by recurrent inhibition in the adult rat in vivo. J Neurophysiol. 2014 Nov 01;112(9):2302-15. PMCID: PMC4274916 |
4. Obeidat AZ, Jacob C, Zabeti A. Concurrent Dawson's Fingers and Area Postrema Lesion in a Mixed Neuroimmune Disorder. Can J Neurol Sci. 2017 Jul;44(4):452-454. |
5. Obeidat AZ, Broderick JP. Teaching Neuro<i>Images</i>: Crying thalamus: Manifestation of acute ischemic stroke. Neurology. 2017 Feb 28;88(9):e72-e73. PMCID: PMC5331865 |
6. Obeidat AZ. Cocaine as a potential trigger for Neuromyelitis Optica. J Neurol Sci. 2018 Jul 15;390:99-101. |
7. Van Sanford C, Obeidat AZ, Hagen M, Zabeti A. A case of fatal invasive aspergillosis in a patient with neurosarcoidosis treated with infliximab. Int J Neurosci. 2019 Jun;129(6):619-622. |
8. Marcucci SB, Obeidat AZ. EBNA1, EBNA2, and EBNA3 link Epstein-Barr virus and hypovitaminosis D in multiple sclerosis pathogenesis. J Neuroimmunol. 2020 Feb 15;339:577116. |
9. Kwon SY, Obeidat AZ, Sekar P, Moomaw CJ, Osborne J, Testai FD, Koch S, Lowe MR, Demel S, Coleman ER, Flaherty M, Woo D. Risk factors for seizures after intracerebral hemorrhage: Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) Study. Clin Neurol Neurosurg. 2020 May;192:105731. PMCID: PMC7183434 |
10. Obeidat AZ, Jassam YN, Hua LH, Cutter G, Ford CC, Halper J, Lisak RP, Sicotte NL, Longbrake EE. Education Research: Multiple sclerosis and neuroimmunology fellowship training status in the United States. Neurology. 2020 Mar 17;94(11):495-500. PMCID: PMC9246053 |
11. Block A, Champeau D, Carlson C, Helms A, Obeidat AZ. Anti-myelin oligodendrocyte glycoprotein (MOG) associated disease masquerading as prolonged intractable nausea and vomiting. Mult Scler Relat Disord. 2020 Sep;44:102308. |
12. Hua LH, Obeidat AZ, Longbrake EE. Outcomes and future directions for neuroimmunology/multiple sclerosis fellowship training: Survey of recent trainees. Mult Scler Relat Disord. 2020 Sep;44:102296. PMCID: PMC8023409 |
13. Hooshmand SI, Chow K, Obeidat AZ. Teaching NeuroImages: Cytotoxic Lesion of the Corpus Callosum Secondary to Influenza A. Neurology. 2021 Mar 23;96(12):e1697-e1698. |
14. Bureau BL, Obeidat A, Dhariwal MS, Jha P. Peripheral Neuropathy as a Complication of SARS-Cov-2. Cureus. 2020 Nov 12;12(11):e11452. PMCID: PMC7673277 |
15. Naismith RT, Bermel RA, Coffey CS, Goodman AD, Fedler J, Kearney M, Klawiter EC, Nakamura K, Narayanan S, Goebel C, Yankey J, Klingner E, Fox RJ, SPRINT-MS investigators. Effects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS Study. Neurology. 2021 Jan 26;96(4):e491-e500. PMCID: PMC7905793 |
16. El-Salem K, Khalil H, Al-Sharman A, Al-Mistarehi AH, Yassin A, Alhayk KA, Qawasmeh MA, Bashayreh SY, Kofahi RM, Obeidat AZ. Serum vitamin d inversely correlates with depression scores in people with multiple sclerosis. Mult Scler Relat Disord. 2021 Feb;48:102732. |
17. Cotchett KR, Dittel BN, Obeidat AZ. Comparison of the Efficacy and Safety of Anti-CD20 B Cells Depleting Drugs in Multiple Sclerosis. Mult Scler Relat Disord. 2021 Apr;49:102787. PMCID: PMC9246073 |
18. Obeidat AZ, Block AN, Hooshmand SI. "Peppering the pons": CLIPPERS or myelin oligodendrocyte glycoprotein associated disease? Mult Scler Relat Disord. 2021 Jun;51:102874. |
19. Nothem ME, Lee RM, Katz JM, Bergl PA, Obeidat AZ. Clinical Reasoning: A 42-Year-Old Woman With Mysterious Monocytic Meningitis. Neurology. 2021 Aug 31;97(9):449-454. |
20. Hua LH, Obeidat AZ, Amezcua L, Cohen JA, Costello K, Dunn J, Gelfand JM, Goldman MD, Hopkins S, Jeffery D, Krieger S. Consensus Curriculum for Fellowship Training in Multiple Sclerosis and Neuroimmunology. Neurology: Clinical Practice. 2021 Jan 18. |
21. Hua LH, Obeidat AZ, Amezcua L, Cohen JA, Costello K, Dunn J, Gelfand JM, Goldman MD, Hopkins S, Jeffery D, Krieger S, Newsome SD, Shah S, Sicotte NL, Yadav V, Longbrake EE. Consensus Curriculum for Fellowship Training in Multiple Sclerosis and Neuroimmunology. Neurol Clin Pract. 2021 Aug;11(4):352-357. PMCID: PMC8382436 |
22. Porwal MH, Patel D, Maynard M, Obeidat AZ. Disproportional increase in psoriasis reports in association with B cell depleting therapies in patients with multiple sclerosis. Mult Scler Relat Disord. 2022 Jul;63:103832. |
23. Burtchell J, Clemmons D, Clemmons J, Sabutis T, Rosenberg A, Graves J, Sweeney ML, Kramer J, Ziehn M, Brown B, Weiss JL, Obeidat AZ. A Targeted Literature Search and Phenomenological Review of Perspectives of People with Multiple Sclerosis and Healthcare Professionals of the Immunology of Disease-Modifying Therapies. Neurol Ther. 2022 Sep;11(3):955-979. PMCID: PMC9127487 |
24. Porwal MH, Salter A, Patel D, Obeidat AZ. Alopecia in Multiple Sclerosis Patients Treated with Disease Modifying Therapies. J Cent Nerv Syst Dis. 2022;14:11795735221109674. PMCID: PMC9234852 |
25. Riem L, Beardsley SA, Obeidat AZ, Schmit BD. Visual oscillation effects on dynamic balance control in people with multiple sclerosis. J Neuroeng Rehabil. 2022 Aug 17;19(1):90. PMCID: PMC9382748 |
26. Porwal MH, Obeidat AZ. Author response to comment on: Alopecia in multiple sclerosis patients treated with disease modifying therapies. J Cent Nerv Syst Dis. 2022;14:11795735221127131. PMCID: PMC9527983 |
27. Drom C, Schenheit K, Matzke M, Obeidat AZ, Molinaro J, Charlson J, Knight JM. Abrupt onset of severe parkinsonism in a patient with metastatic gastrointestinal stromal tumor receiving treatment with avapritinib: A case report. Brain Behav Immun Health. 2023 Feb;27:100570. PMCID: PMC9791578 |
28. Titcomb TJ, Bostick M, Obeidat AZ. Opinion: The role of the registered dietitian nutritionist in multiple sclerosis care in the United States. Front Neurol. 2023;14:1068358. PMCID: PMC9947712 |
29. Obeidat AZ, Ketchum NC. Multiple sclerosis-related spasticity Handbook of Spasticity: A Practical Approach to Management. 15 September 2023:305-315. |
30. Esmaeili S, Obeidat AZ, Zabeti A. Molecular biomarkers and cognitive impairment in multiple sclerosis: A review Biomarkers in Neuropsychiatry. December 2023;9. |
31. Porwal MH, Obeidat AZ. A closer look at reported colitis in association with multiple sclerosis treatments. Mult Scler. 2024 Mar;30(3):453-455. |
32. Meylor J, Artunduaga DC, Mendoza M, Hooshmand SI, Obeidat AZ. Progressive multifocal leukoencephalopathy in patients with chronic kidney disease. Neurol Sci. 2024 Apr;45(4):1619-1624. |
33. Palathinkara M, Razzak AN, Ababneh OE, Cairns D, Obeidat AZ. Clinical and radiologic differences between early onset, late onset, and very late onset adult multiple sclerosis. Mult Scler Relat Disord. 2023 Dec;80:105132. |
34. Obeidat AZ. Time to involve the multiple sclerosis expert community at large when revising the McDonald diagnostic criteria. Mult Scler Relat Disord. 2024 Feb;82:105389. |
35. Razzak AN, Hernandez RS, Salter A, Obeidat AZ. Increased healthcare utilization in the year before multiple sclerosis diagnosis. Mult Scler Relat Disord. 2024 Mar;83:105438. |
36. Vermersch P, Granziera C, Mao-Draayer Y, Cutter G, Kalbus O, Staikov I, Dufek M, Saubadu S, Bejuit R, Truffinet P, Djukic B, Wallstroem E, Giovannoni G, Frexalimab Phase 2 Trial Group. Inhibition of CD40L with Frexalimab in Multiple Sclerosis. N Engl J Med. 2024 Feb 15;390(7):589-600. |
37. Hjerthen IG, Trápaga Hacker C, Meador W, Obeidat AZ, Horta L, Mateen FJ. Impact of neuromyelitis optica spectrum disorder on employment and income in the United States. Ann Clin Transl Neurol. 2024 Apr;11(4):1011-1020. PMCID: PMC11021617 |
38. Peters J, Cohen JA, Corboy JR, Hopkins SE, Hua LH, Kakara M, McFaul D, Obeidat AZ, Yadav V, Longbrake EE. Curriculum Innovations: Virtual Didactics as a Tool for Harmonizing Education About Rare Topics in Neuroimmunology. Neurol Educ. 2022 Sep;1(1). PMCID: PMC11081105 |
39. Porwal MH, Razzak AN, Kumar V, Obeidat AZ, Sharma U. An analysis of suicidal and self-injurious behavior reports with antiseizure medications in the FDA adverse event database. Epilepsy Res. 2024 Jul;203:107382. |
40. Obeidat AZ. JC virus or extended interval dosing? More data are needed. Mult Scler. 2024 Nov;30(13):1698. |
41. Nerenz RD, Hooshmand SI, Jackowiak E, Shirilla D, Yang Y, Yang K, Obeidat AZ. Clinical decision support improves autoimmune/paraneoplastic antibody panel utilization. Am J Clin Pathol. 2025 Jan 28;163(1):109-120. |
42. Gurski CJ, Hajiyeva Z, Veltri AJ, Fenton K, O'Dell S, Obeidat AZ, Dittel BN. Elevated frequencies of activated memory B cells in multiple sclerosis are reset to healthy control levels after B cell depletion with Ocrelizumab. J Neuroimmunol. 2025 Feb 15;399:578502. |
43. Hamna Khan, Michelle Maynard, Ahmed Z Obeidat. Cardiac events in the setting of ofatumumab treatment: An association or A Co-incidence? Neuroimmunology Reports. Khan, Hamna, Michelle Maynard, and Ahmed Z. Obeidat. "Cardiac events in the setting of ofatumumab treatment: An association or A Co-incidence?." Neuroimmunology Reports 6 (2024): 1. |
44. Gurski CJ, Hajiyeva Z, Veltri AJ, Fenton K, O'Dell S, Obeidat AZ, Dittel BN. Corrigendum to "Elevated frequencies of activated memory B cells in multiple sclerosis are reset to healthy control levels are B cell depletion with Ocrelizumab" [J. Neuroimmunol. 339:578502 (2024)]. J Neuroimmunol. 2025 Feb 15;399:578519. |
Books, Chapters, and Reviews |
1. Chirra M, Marsili L, Wattley L, Sokol LL, Keeling E, Maule S, Sobrero G, Artusi CA, Romagnolo A, Zibetti M, Lopiano L, Espay AJ, Obeidat AZ, Merola A. Telemedicine in Neurological Disorders: Opportunities and Challenges. Telemed J E Health. 2019 Jul;25(7):541-550. PMCID: PMC6664824 |
Editorials, Letters To Editor, Other |
1. Obeidat AZ. John F. Kurtzke, MD (1926-2015). Neuroepidemiology. 2016;46(2):118-9. |
2. Obeidat A. Disconnection. Perm J. 2016;20(3):15-165. PMCID: PMC4991925 |
3. Obeidat AZ. Her Glistening Eyes. Perm J. 2016;20(4):15-227. PMCID: PMC5101105 |
4. Ahmed Z. Obeidat. Fragile Scream Neurology. Neurology Feb 2018, 90 (9) 427; DOI: 10.1212/WNL.0000000000005015. |
5. Al-Khun N, Obeidat AZ. The unseen but felt. Neurology. 2018 Feb 27;90(9):428. |
6. Obeidat AZ, Al-Khun N. Balloons of Hope. Perm J. 2018;22:18-024. PMCID: PMC6047848 |
7. Obeidat AZ. Time Is Brain and Spine. JAMA Neurol. 2019 May 01;76(5):623. |
8. Obeidat AZ, El-Salem K. A national telemedicine program in the Kingdom of Jordan - Editorial. Ann Med Surg (Lond). 2021 Feb;62:145-149. PMCID: PMC7820302 |
9. Obeidat AZ. Reader response: Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors. |
10. Obeidat, AZ. E-Pearl on Neurology Podcast: Immunotherapy responsive seizures, posted online at www.neurology.org on 11/23/2015 |
Abstracts |
1. Hooshmand S, Obeidat A, Brod S. Reactivation of Latent Neuromyelitis Optic Secondary to COVID-19 Infection: A Case Report (4562). |
2. Hooshmand S, Brod S, Obeidat A. Transverse Myelitis as a Presenting Sign of Intravascular Lymphoma: A Report of Two Cases (2902). |
3. Block A, Bureau BL, Cotter A, Kamalia M, Jha P, Obeidat A. Intravenous Immunoglobulin Use in West Nile Encephalitis: A report of two cases.(5081). |
4. Block AN, Obeidat AZ. (CRS01) Seasonal Variation and Other Observations in Myelin Oligodendrocyte Glycoprotein (MOG) Antibody--Associated Disease. International Journal of MS Care. 2020 May 2;22. |
5. Carlisle N, Hooshmand SI, Maynard M, Obeidat AZ. (CRS11) Remarkable Recovery of Fulminant Multiple Sclerosis After Treatment Induction with Cyclophosphamide. International Journal of MS Care. 2020 May 2;22. |
6. Carlisle N, Hooshmand SI, Maynard M, Hoffman L, Obeidat AZ. (DXT55) Herpes Zoster Virus (HZV) Infections Among Multiple Sclerosis Patients Treated with Various Disease-Modifying Therapies. International Journal of MS Care. 2020 May 2;22. |
7. Longbrake E, Obeidat A, Dunn J, Sicotte N, Hua L. Defining the Neuroimmunology/Multiple Sclerosis Subspecialty: Surveys of Fellowship Training in the United States (699). |
8. Aladawi M, Salter A, Maynard M, Obeidat A. Ma2 paraneoplastic limbic encephalitis: Examination of potential prognostic factors and effects of various immunotherapeutic approaches (4894). |
9. Hooshmand S, Carlisle N, Maynard M, Hoffman L, Obeidat A. Analysis of Reported Deaths While Exposed to Disease-Modifying Therapies for Multiple Sclerosis (2855). |
10. Block AN, Maynard M, Obeidat AZ. Novel Clinical Observations in Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Disorders. In2019 Annual Meeting of the Consortium of Multiple Sclerosis Centers 2019 May 30. CMSC. |
11. Obeidat A, Annadurai V, Zabeti A, Goldstick L. The Middle Cerebellar Peduncle Lesion in Natalizumab-Treated Multiple Sclerosis Patients: Think Twice Before Assuming a Relapse (P5. 349). |
12. Obeidat AZ, Bowman M, Dragan E, Goldstick L, Zabeti A. Low Dose Naltrexone in Multiple Sclerosis: Web-Presence Versus Scientific Evidence. InMULTIPLE SCLEROSIS JOURNAL 2018 Feb 1 (Vol. 24, pp. 76-76). 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND: SAGE PUBLICATIONS LTD. |
13. Annadurai V, Zabeti A, Illingworth AA, Obeidat AZ. Rapid Evolution of Natalizumab-Associated Brainstem PML–IRIS: Lessons Learned in Diagnosis and Management. InMultiple Sclerosis Journal 2018 Feb 1 (Vol. 24, pp. 46-47). 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND: SAGE PUBLICATIONS LTD. |
14. Obeidat AZ, Subbiah B, Tomsick T, Khatri P. Developmental Venous Anomalies in Neurological Disease: A Report of Six Cases (P4. 059). |
15. Obeidat AZ, Subbiah B, Zabeti A. On the History of Multiple Sclerosis and War (P2. 044). |
16. Van Sanford C, Obeidat A, Zabeti A. Ring Enhancing Brain Lesions in a Patient With Sarcoidosis: A Diagnostic Challenge.(P1. 306). |
17. Obeidat AZ, Dragan E, Zabeti A. The 10-Point Disability Scale in Multiple Sclerosis: Phase I Development and Planning study (P2. 062). |
18. Obeidat AZ, Ramirez R, Halper J. The Status of Multiple Sclerosis and Neuroimmunology Fellowship Training in the United States: A Pilot Study. InACTRIMS Forum 2017 2017 Feb 23. ACTRIMS. |
19. Obeidat AZ, Jacob CA, Zabeti A. Neuromyelitis optica was the answer! Not lupus or sjogren. InACTRIMS Forum 2016 2016 Feb 19. ACTRIMS. |
20. Obeidat AZ, Sucharew H, Moomaw CJ, Kleindorfer DO, Kissela BM, Alwell K, Flaherty M, Broderick JP, Woo D. Abstract WP190: Clinical Features of Sarcoid Patients With Ischemic Stroke. Stroke. 2016 Feb;47(suppl_1):AWP190-. |
21. Obeidat AZ, Sucharew H, Moomaw CJ, Kleindorfer DO, Kissela BM, Alwell K, Flaherty M, Broderick JP, Woo D. Abstract WP190: Clinical Features of Sarcoid Patients With Ischemic Stroke. Stroke. 2016 Feb;47(suppl_1):AWP190-. |
22. Obeidat A, Zabeti A. A Case of Duane Syndrome, Developmental Venous Anomalies, Hydrocephalus, and Multiple Sclerosis: Possible Link or Just a Co-Incidence?(P4. 075). |
23. Obeidat A. Localization of fluorescent probes in rat brain tissue stained with hematoxylin: a methodology development study. Celebration of Research, Scholarship, and Creative Activities. 2010. |
24. Obeidat AZ, Cope TC. The Recurrent Debate on Renshaw Inhibition and Spinal Motoneuron Firing Behavior. Gordon Research Conferences: Inhibition in the CNS. Accepted for poster presentation. Lewiston, ME, 8/2015.
|
25. Obeidat AZ, Cope TC. The Musical Notes of Motoneuron Firing. Society for Music, Perception and Cognition Meeting. Accepted for poster presentation, Nashville, TN,
8/2015.
|
26. Obeidat AZ, Zabeti A. Delayed Tumefactive Demyelination in a Patient with Meningioma and Optic Neuritis: Case Report and Review of the Literature. The Consortium of Multiple Sclerosis Centers Annual Meeting. Accepted for poster presentation. Indianapolis, IN, 5/2015.
|
27. Obeidat AZ, Zabeti A. Appearance of Balo’s Concentric Sclerosis Eighteen Years
after Acute Psychosis. The Consortium of Multiple Sclerosis Centers annual meeting. Accepted for poster presentation. Indianapolis, IN, 5/2015.
|
28. Obeidat AZ, Cope TC, Diminished Participation of Regenerated Motoneurons in Recurrent Inhibitory Circuits. Cellular and Network Functions in the Spinal Cord Symposium. Madison, WI, 5/2012.
|
29. Obeidat AZ, Nardelli P, Powers RK, and Cope TC. Recurrent Inhibition and Motoneuron Firing Behavior: Rate, Timing, Adaptation. Program No. 745.09. 2013 Neuroscience Meeting Planner. Society for Neuroscience Annual Meeting. San Diego, CA
|
30. Obeidat AZ, Cope TC. Stressful Life Events and Multiple Sclerosis: A Call for Re-Evaluation. The Consortium of Multiple Sclerosis Centers Annual Meeting. Orlando, FL, 5/2013.
|
31. Obeidat AZ, Nardelli P, Powers RK, Cope TC. Recurrent Inhibition and Motoneuron Firing Behavior: Rate, Timing, Adaptation. Ohio Miami Valley Neuroscience Day Symposium. Cincinnati, Ohio, 6/2013.
|
32. Obeidat AZ, Cope TC. Firing Rate Modulation by Recurrent Inhibition in Adult Rat Motoneurons. Program No. 789.09. 2012 Neuroscience Meeting Planner. Society for Neuroscience Annual Meeting. New Orleans, LA, 10/2012.
|
33. Obeidat AZ, Rotterman TM, Alvarez FJ, Cope TC. Global Changes in Recurrent Inhibition Following Peripheral Nerve Repair. Program No. 789.12. 2012 Neuroscience Meeting Planner. Society for Neuroscience Annual Meeting. New Orleans, LA, 10/2012.
|
34. Obeidat AZ, Cope TC, Modulation of Afterhyperpolarization by Recurrent Inhibition. Cellular and Network Functions in the Spinal Cord Symposium. Madison, WI, 5/2012.
|
35. Obeidat AZ, Rotterman T M, Nardelli P, Alvarez FJ, Cope TC, Regeneration Fails to Restore Spinal Circuits, Ohio Miami Valley Neuroscience Day Symposium. Oxford, Ohio, 5/2012.
|
36. Obeidat AZ, Rotterman T M, Nardelli P, Alvarez FJ, Cope TC, Permanent Alterations in Recurrent Inhibition after Peripheral Nerve Injury. Program No. 74.24. 2011 Neuroscience Meeting Planner. Society for Neuroscience Annual Meeting. Washington, DC 11/2011.
|
37. Spokane RB, Kent MN, Nagy JO, Obeidat AZ, Leasure JE, Johnson JM, Olson JE, Novel Nanoparticles for Delivering Magnetic Resonance Contrast Agents Across the Blood-Brain Barrier. Program No.714.5. 2010. Neuroscience Meeting Planner. Society for Neuroscience Annual Meeting. San Diego, CA, 11/2010.
|
38. Obeidat AZ, Variations of Neural Tube Defects in Jordan. The17th Conference of the Union of Arab Pediatricians and the Fifth Meeting of the Pan Arab Neonatology Forum. Amman, Jordan, 5/2009
|